肥胖对miRNome的影响:miR-4454通过调节剪接过程在前列腺中调控胰岛素反应的关键作用
研究通过miRNA芯片发现肥胖者血浆中26个miRNA改变(P<0.01),并在两个独立队列中验证miR-4454在肥胖中持续升高,与胰岛素抵抗相关且受二甲双胍/他汀类药物和减重手术调节。体外实验显示miR-4454过表达可降低前列腺细胞INSR、GLUT4表达及AMPK/AKT/ERK磷酸化,并改变剪接体组分和胰岛素受体剪接变体表达。
要点
- 肥胖者血浆miR-4454水平持续升高,与胰岛素抵抗相关。
- miR-4454受二甲双胍/他汀类药物及减重手术调节。
- miR-4454过表达可损害前列腺细胞胰岛素信号通路。
核心结论
- 肥胖与血浆miRNA谱改变相关,其中miR-4454水平升高,与胰岛素抵抗相关并受肥胖控制干预调节。
- 胰岛素调控miR-4454,后者可能通过调节剪接过程以细胞类型依赖方式(如前列腺)损害细胞对胰岛素的反应。
研究设计与样本
- 在体重正常(n=4,BMI<25)和肥胖受试者(n=4,BMI>30)血浆中进行Affymetrix-miRNA芯片检测。
- 在2个独立队列(n=221/n=18)中验证主要变化。
- 进行计算机模拟方法,并在组织样本及前列腺(RWPE-1)和肝脏(HepG2)细胞系中进行体外实验。
主要发现
- Affymetrix-miRNA芯片显示肥胖受试者血浆中26个miRNA改变(P<0.01)。
- 在更大队列验证中,miR-4454水平在肥胖中持续升高,与胰岛素抵抗(稳态模型评估胰岛素抵抗/胰岛素)相关。
- miR-4454受药物(二甲双胍/他汀类)和手术(减重手术)策略调节。
- miR-4454在前列腺和肝脏组织中高表达,胰岛素可增加前列腺和肝脏细胞中其表达。
- 在前列腺细胞中过表达miR-4454导致INSR、GLUT4表达水平降低及AMPK/AKT/ERK磷酸化降低,并改变关键剪接体组分(ESRP1/ESRP2/RBM45/RNU2)和胰岛素受体剪接变体的表达。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Obesity is a major health problem associated with severe comorbidities, including type 2 diabetes and cancer, wherein microRNAs (miRNAs) might be useful as diagnostic/prognostic tools or therapeutic targets. OBJECTIVE: To explore the differential expression pattern of miRNAs in obesity and their putative role in obesity-related comorbidities such as insulin resistance. METHODS: An Affymetrix-miRNA array was performed in plasma samples from normoweight (n = 4/body mass index < 25) and obese subjects (n = 4/body mass index > 30). The main changes were validated in 2 independent cohorts (n = 221/n = 18). Additionally, in silico approaches were performed and in vitro assays applied in tissue samples and prostate (RWPE-1) and liver (HepG2) cell-lines. RESULTS: A total of 26 microRNAs were altered (P < 0.01) in plasma of obese subjects compared to controls using the Affymetrix-miRNA array. Validation in ampler cohorts revealed that miR-4454 levels were consistently higher in obesity, associated with insulin-resistance (Homeostatic Model Assessment of Insulin Resistance/insulin) and modulated by medical (metformin/statins) and surgical (bariatric surgery) strategies. miR-4454 was highly expressed in prostate and liver tissues and its expression was increased in prostate and liver cells by insulin. In vitro, overexpression of miR-4454 in prostate cells resulted in decreased expression levels of INSR, GLUT4, and phosphorylation of AMPK/AKT/ERK, as well as in altered expression of key spliceosome components (ESRP1/ESRP2/RBM45/RNU2) and insulin-receptor splicing variants. CONCLUSIONS: Obesity was associated to an alteration of the plasmatic miRNA landscape, wherein miR-4454 levels were higher, associated with insulin-resistance and modulated by obesity-controlling interventions. Insulin regulated miR-4454, which, in turn may impair the cellular response to insulin, in a cell type-dependent manner (i.e., prostate gland), by modulating the splicing process.
引用
- Herrero-Aguayo V, Jiménez-Vacas JM, Sáez-Martínez P, et al. Influence of Obesity in the miRNome: miR-4454, a Key Regulator of Insulin Response Via Splicing Modulation in Prostate. J Clin Endocrinol Metab. 2021. PMID: 32841353. doi:10.1210/clinem/dgaa580
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。